---
schema_version: "secwatch.filing_event.v1"
accession: "0001555280-25-000259"
form_type: "8-K"
ticker: "ZTS"
cik: "0001555280"
company_name: "Zoetis Inc."
filed_at: "2025-08-05T23:59:59+00:00"
generated_at: "2026-05-17T20:39:52.835805+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Zoetis Q2 revenue $2.5B (+4% reported, +8% organic); raises FY2025 guidance

## Summary
- Reported net income $718M ($1.61 diluted EPS), up 15% YoY; adjusted EPS $1.76, up 13%.
- U.S. segment revenue $1.4B (+4% reported, +7% organic); companion animal product sales up 9%.
- International segment revenue $1.1B (+3% reported, +9% organic); livestock sales up 10% organic.
- Raised FY2025 revenue guidance to $9.45-9.60B (organic growth 6.5-8.0%); adjusted EPS $6.30-6.40.
- Simparica Trio gained new label in Japan; avian influenza vaccine conditionally licensed for U.S. dairy cattle.

## SEC filing metadata
- accession: 0001555280-25-000259
- form_type: 8-K
- ticker: ZTS
- cik: 0001555280
- company_name: Zoetis Inc.
- filed_at: 2025-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1555280/000155528025000259/0001555280-25-000259-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1555280/000155528025000259/zts-20250805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001555280-25-000259
- JSON: https://secwatch.observer/filing/0001555280-25-000259.json
- Plain text: https://secwatch.observer/filing/0001555280-25-000259.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.